UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Real world data in colorectal cancer: A retrospective analysis of overall survival in metastatic colorectal cancer patients between 2011-2015 treated in Spain, preliminary results (RWD-ACROSS study)

Annals of oncology, 2018-06, Vol.29, p.v78-v78

2018

Volltextzugriff (PDF)

Complete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens

Annals of oncology, 2018-10, Vol.29, p.viii74-viii74

2018

Volltextzugriff (PDF)

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer

Annals of oncology, 2017-08, Vol.28 (8), p.2027-2028

2017

Volltextzugriff (PDF)

338P A new clinically applicable immune-metabolic signature (IMMETCOLS) reveals metabolic singularities in consensus molecular subtypes (CMS) in colorectal cancer

Annals of oncology, 2022-09, Vol.33, p.S691

2022

Volltextzugriff (PDF)

A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection

International journal of colorectal disease, 2020-05, Vol.35 (5), p.921-927

2020

Volltextzugriff (PDF)

763P Combined gene signature (T-cell inflamed gene expression profile – TcellinfGEP – & IMMETCOLS) identifies a metabolic rewiring program, key for immune evasion

Annals of oncology, 2022-09, Vol.33, p.S891-S892

2022

Volltextzugriff (PDF)

P-228 Phase II multicentric randomized controlled trial to compare first-line treatment with FOLFOX6m + mAB alone or in combination with liver chemoembolization (Lifepearls-Irinotecan) in poor prognosis colorectal cancer with liver-limited disease

Annals of oncology, 2021-07, Vol.32, p.S177

2021

Volltextzugriff (PDF)

433P Pre-treatment and post-treatment MRI extramural venous invasion, predicts disease-free survival and overall survival, in locally advanced rectal cancer

Annals of oncology, 2022-09, Vol.33, p.S732

2022

Volltextzugriff (PDF)

605P First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort

Annals of oncology, 2023-10, Vol.34, p.S435-S435

2023

Volltextzugriff (PDF)

996P An immune-metabolic signature correlates with immune-suppressive patterns and with outcome, across tumor types

Annals of oncology, 2021-09, Vol.32, p.S847-S847

2021

Volltextzugriff (PDF)

416P Randomized phase II trial of second-line FOLFIRI-panitumumab vs FOLFIRI alone in Ras wild type (wt) metastatic colorectal cancer (mCRC) patients beyond progression to first-line FOLFOX-panitumumab: BEYOND study (GEMCAD 17-01)

Annals of oncology, 2021-09, Vol.32, p.S543-S543

2021

Volltextzugriff (PDF)

476P Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis

Annals of oncology, 2020-09, Vol.31, p.S443-S443

2020

Volltextzugriff (PDF)

442P A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)

Annals of oncology, 2021-09, Vol.32, p.S555-S555

2021

Volltextzugriff (PDF)

92P First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA)

Annals of oncology, 2021-09, Vol.32, p.S396-S397

2021

Volltextzugriff (PDF)

2P Lung immune prognostic index (LIPI) can identify the fast-progressor to immune checkpoints inhibitors (ICI) in microsatellite instability (MSI) or mismatch repair deficient (dMMR) tumours

Annals of oncology, 2020-12, Vol.31, p.S1418-S1418

2020

Volltextzugriff (PDF)

471P Identification and validation of a new prognostic score in metastatic colorectal cancer (mCRC): GEMCAD score

Annals of oncology, 2020-09, Vol.31, p.S441-S441

2020

Volltextzugriff (PDF)

1481P Expression of ERBB2 and PD1 mRNA in advanced gastric cancer

Annals of oncology, 2020-09, Vol.31, p.S922-S923

2020

Volltextzugriff (PDF)

1714P Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score

Annals of oncology, 2020-09, Vol.31, p.S1008-S1008

2020

Volltextzugriff (PDF)

548P Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT)

Annals of oncology, 2020-09, Vol.31, p.S477-S477

2020

Volltextzugriff (PDF)

P-277Real world data in colorectal cancer: A retrospective analysis of overall survival in metastatic colorectal cancer patients between 2011-2015 treated in Spain, preliminary results (RWD-ACROSS study)

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

230PComplete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer

Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Vol.28 (8), p.2027-2028

2017

Volltextzugriff (PDF)

Tuning Lewis Acidity of Metal–Organic Frameworks via Perfluorination of Bridging Ligands: Spectroscopic, Theoretical, and Catalytic Studies

Journal of the American Chemical Society, 2018-08, Vol.140 (33), p.10553-10561

2018

Volltextzugriff (PDF)

Harald Schmidt - Zur Ästhetik und Praxis des Populären

2023

Volltextzugriff (PDF)

Harald Schmidt - Zur Ästhetik und Praxis des Populären

2022

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Deutsch
(72)
Englisch
(32)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Media Studies
(20)
Philosophy
(20)
Popular Culture
(19)
Commercial Law
(7)
Science & Technology
(6)
Life Sciences & Biomedicine
(5)
Aufsatzsammlung
(4)
Humans
(3)
Social Sciences
(3)
Aesthetics
(2)
Aged
(2)
Business
(2)
Cardiac & Cardiovascular Systems
(2)
Cardiovascular & Respiratory Systems
(2)
Cardiovascular System & Cardiology
(2)
Criticism And Interpretation
(2)
Cultural Studies
(2)
Deutschland
(2)
Human Health Sciences
(2)
Law
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real world data in colorectal cancer: A retrospective analysis of overall survival in metastatic colorectal cancer patients between 2011-2015 treated in Spain, preliminary results (RWD-ACROSS study)

Complete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer

338P A new clinically applicable immune-metabolic signature (IMMETCOLS) reveals metabolic singularities in consensus molecular subtypes (CMS) in colorectal cancer

A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection

763P Combined gene signature (T-cell inflamed gene expression profile – TcellinfGEP – & IMMETCOLS) identifies a metabolic rewiring program, key for immune evasion

P-228 Phase II multicentric randomized controlled trial to compare first-line treatment with FOLFOX6m + mAB alone or in combination with liver chemoembolization (Lifepearls-Irinotecan) in poor prognosis colorectal cancer with liver-limited disease

433P Pre-treatment and post-treatment MRI extramural venous invasion, predicts disease-free survival and overall survival, in locally advanced rectal cancer

605P First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort

996P An immune-metabolic signature correlates with immune-suppressive patterns and with outcome, across tumor types

416P Randomized phase II trial of second-line FOLFIRI-panitumumab vs FOLFIRI alone in Ras wild type (wt) metastatic colorectal cancer (mCRC) patients beyond progression to first-line FOLFOX-panitumumab: BEYOND study (GEMCAD 17-01)

476P Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis

442P A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)

92P First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA)

2P Lung immune prognostic index (LIPI) can identify the fast-progressor to immune checkpoints inhibitors (ICI) in microsatellite instability (MSI) or mismatch repair deficient (dMMR) tumours

471P Identification and validation of a new prognostic score in metastatic colorectal cancer (mCRC): GEMCAD score

1481P Expression of ERBB2 and PD1 mRNA in advanced gastric cancer

1714P Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score

548P Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT)

P-277Real world data in colorectal cancer: A retrospective analysis of overall survival in metastatic colorectal cancer patients between 2011-2015 treated in Spain, preliminary results (RWD-ACROSS study)

230PComplete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer

Tuning Lewis Acidity of Metal–Organic Frameworks via Perfluorination of Bridging Ligands: Spectroscopic, Theoretical, and Catalytic Studies

Harald Schmidt - Zur Ästhetik und Praxis des Populären

Harald Schmidt - Zur Ästhetik und Praxis des Populären

Suchergebnisse filtern